General MedicationsINJECTIONStandard
ROPIVACAINE HYDROCHLORIDE
ROPIVACAINE HYDROCHLORIDE
Standard Dose
150MG/20ML (7.5MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ROPIVACAINE HYDROCHLORIDE is listed in Drugs@FDA under application 218713 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ROPIVACAINE HYDROCHLORIDE Form and strength SOLUTION;INJECTION - 150MG/20ML (7.5MG/ML) Sponsor KINDOS Submission history Latest submission status date: 2024-07-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview ROPIVACAINE HYDROCHLORIDE is listed in Drugs@FDA under application 218713 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ROPIVACAINE HYDROCHLORIDE Form and strength SOLUTION;INJECTION - 150MG/20ML (7.5MG/ML) Sponsor KINDOS Submission history Latest submission status date: 2024-07-30 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.